Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: China Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20122
20132
20142
20151
20162
20175
20185
20194
20204
20215
20228
202310
20249
202515
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting27
Unknown status25
Completed15
Enrolling by invitation4
Not yet recruiting3
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd5
Affiliated Hospital of Jiangnan University2
Base Therapeutics (Shanghai) Co., Ltd.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Eli Lilly and Company2
Jiangsu HengRui Medicine Co., Ltd.2
Peking University2
Seagen, a wholly owned subsidiary of Pfizer2
Shanghai PerHum Therapeutics Co., Ltd.2
Shanghai Yunying Medical Technology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms80
Breast Neoplasms22
Pancreatic Neoplasms22
Colorectal Neoplasms21
Esophageal Neoplasms14
Carcinoma, Non-Small-Cell Lung9
Ovarian Neoplasms9
Lung Neoplasms8
Neoplasm Metastasis8
Endometrial Neoplasms7

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.